Literature DB >> 27455055

Mumps virus pathogenesis: Insights and knowledge gaps.

Sigrid Gouma1,2, Marion P G Koopmans1,2, Rob S van Binnendijk1.   

Abstract

The recent mumps outbreaks among MMR vaccinated persons have raised questions about the biological mechanisms related to mumps symptoms and complications in the background of waning immunity. Contrary to other paramyxoviruses, the understanding of mumps virus pathogenesis is limited, and further in-depth clinical studies are required to provide answers to important research questions.

Entities:  

Keywords:  MMR vaccination; Mumps virus; T cell immunity; mucosal immunity; orchitis; parotitis; symptoms; viruria

Mesh：

Year:  2016        PMID： 27455055      PMCID： PMC5215468          DOI： 10.1080/21645515.2016.1210745

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  37 in total

Review 1.  Mumps and the UK epidemic 2005.

Authors:  Ravindra K Gupta; Jennifer Best; Eithne MacMahon
Journal:  BMJ       Date:  2005-05-14

2.  Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.

Authors:  Mona Marin; Patricia Quinlisk; Tom Shimabukuro; Charu Sawhney; Cedric Brown; Charles W Lebaron
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

3.  Genotyping and subtyping of mumps virus isolates from the Indian subcontinent.

Authors:  Baijayantimala Mishra; Sujit Kumar Pujhari; Vandana Dhiman; P Mahalakshmi; Abhinav Bharadwaj; Sandeep Pokhrel; Deepak Sharma; Mirnalini Sharma; Deepak Bhatia; Radha Kanta Ratho
Journal:  Arch Virol       Date:  2013-05-18       Impact factor: 2.574

4.  Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students.

Authors:  Toon Braeye; Indra Linina; Rikka De Roy; Veronik Hutse; Magali Wauters; Pia Cox; Ruud Mak
Journal:  Vaccine       Date:  2014-06-25       Impact factor: 3.641

Review 5.  Exploiting Mucosal Immunity for Antiviral Vaccines.

Authors:  Akiko Iwasaki
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

6.  Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization.

Authors:  Dihan Zhou; Yan Zhang; Qiaoli Li; Yaoqing Chen; Benxia He; Jingyi Yang; Haobo Tu; Lei Lei; Huimin Yan
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

7.  Pathogenicity of mumps virus in the marmoset.

Authors:  Shizuko Saika; Minoru Kidokoro; Tokitada Ohkawa; Atuko Aoki; Kazuyoshi Suzuki
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

Review 8.  Host response to respiratory syncytial virus infection.

Authors:  Lourdes Arruvito; Silvina Raiden; Jorge Geffner
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

Review 9.  Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanism.

Authors:  Vanessa Clifford; Jane Wadsley; Bernard Jenner; Jim P Buttery
Journal:  Vaccine       Date:  2010-01-17       Impact factor: 3.641

10.  Mumps vaccine performance among university students during a mumps outbreak.

Authors:  Margaret M Cortese; Hannah T Jordan; Aaron T Curns; Patricia A Quinlan; Kim A Ens; Patricia M Denning; Gustavo H Dayan
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079
View more
  3 in total

1.  Measles, mumps, and rubella: A cross-sectional study of susceptibility to vaccine-preventable diseases among young people in India.

Authors:  Santosh Karade; Sourav Sen; V K Sashindran; Punita Sharma; Madhuri Kanitkar
Journal:  Med J Armed Forces India       Date:  2019-01-18

2.  Meta-analysis of the effects of ambient temperature and relative humidity on the risk of mumps.

Authors:  Taiwu Wang; Junjun Wang; Jixian Rao; Yifang Han; Zhenghan Luo; Lingru Jia; Leru Chen; Chunhui Wang; Yao Zhang; Jinhai Zhang
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

3.  Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.

Authors:  Stéphanie Ravault; Damien Friel; Emmanuel Di Paolo; Adrian Caplanusi; Paul Gillard; Michael Povey; Stephane Carryn
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.